SUMMARY Six infants with severe life-threatening protracted diarrhoea were treated with loperamide. Steady-state perfusion studies of the jejunum showed that in 2 of them the small intestine was in a net secretory state with respect to water, and in the others this was inferred from the fact that the diarrhoea persisted despite nothing by mouth. Loperamide resulted in a prompt and impressive improvement in the condition of each infant. We conclude that this drug has an important role in the management of protracted diarrhoeal states in some infants who are unresponsive to current treatments, and that its effect is related to its antisecretory action.
Loperamide (Imodium), an opiate analogue, has been shown to be an effective antidiarrhoeal agent in adults,'-5 its effect being attributed to an action on smooth muscle and intestinal motility.6 7 However, our clinical observations which are reported in this paper prompted us to question whether the drug also had an effect on the intestinal absorption of fluid and electrolytes in the experimental animal, and it was subsequently shown to be a potent antisecretory agent.8-"
The pathogenesis and management of certain protracted diarrhoeal states in infancy continue to pose important questions, and morbidity and mortality may be very high. '2-'6 In this paper, we report 6 infants with severe and life-threatening protracted diarrhoea who were successfully treated with loperamide.
Materials and methods
Dosage of loperamide. The daily mean ± 1 SD dosage of loperamide in the 6 patients was 1 -26 ± 0 94 mg/kg actual body weight, and 0 68 0.44 mg per expected (that is assuming weight to be on the 50th centile for age) body weight. The total daily amount of administered loperamide was given in divided doses (see below).
Perfusion studies. Steady-state perfusion studies were performed in 20-cm segments of proximal jejunum using a double lumen tube at a rate of 8 ml/min as previously described.'7 All the solutions perfused contained polyethylene glycol (4000) 3 g/l, KCI 39 4 mmol/l, NaHCo3 25 mmol/l, and either no added sugar or fructose 20 mmol/l and glucose 2 mmol/l, or glucose 56 mmol/l. The solutions were then made isotonic by the addition of NaCl and gassed with Co2 to a pH of 7.
Case reports.
Case I
He was the third child of healthy unrelated parents, born at term by caesarean section weighing 2-8 kg; there were no neonatal problems and no relevant family history. He remained well until age 9 months when he developed severe watery diarrhoea which necessitated admission to hospital and treatment with intravenous fluids. Escherichia coli and Shigella sonnei were cultured from the stools. He passed 400-600 ml of stool daily despite nothing by mouth. His condition deteriorated with electrolyte imbalance and generalised convulsions, and was transferred to The Hospital for Sick Children at age 9 5 months. On arrival his weight was 7.2 kg (<3rd centile), he was severely dehydrated with cold extremities, and was semicomatose. After resuscitation and rehydration, parenteral nutrition was started via a central vein and he continued to pass 400-600 ml of stool daily while having nothing by mouth. No pathogens were cultured from the stools. Normal results were obtained from the following investigations which included a full immunological screen, jejunal biopsy, cultures of jejunal juice, and plasma vasoactive intestinal peptide hormone. A perfusion study showed net jejunal secretion of water which was greatly reduced by the addition of glucose (56 mmol/l) to the perfusate (Table) . The addition of loperamide (16 mg/i) to the perfusate had no effect on secretion during the subsequent 2-hour perfusion period, and this was presumably owing to an effect of loperamide which is time related; the addition of glucose to the perfusate again modified net secretion of fluid in a reproducible fashion. A striking reduction in daily stool volume was noted the next day but 48 hours later it had returned to preperfusion level (Fig. 1) . In view of this observation, loperamide in a dose of 8 mg/day (1 mg/kg per 24 hours) was given orally in 4 divided doses, and again a similar reduction in stool volume occurred (Fig. 1) (Table) . Diarrhoea persisted despite nothing by mouth and parenteral nutrition was necessary, as for Cases 3, 4, and 5. At age 21 months he weighed only 5 kg, daily stool volume varied between 200 and 600 ml, and he remained dependent on parenteral nutrition. At 22 months loperamide was introduced in a dose of 2 mg 4 times a day (1 -5 mg/kg per day) and there was a rapid reduction in stool volume to 30-80 ml daily within 24 hours (Fig. 2) . Oral feeding with a chicken-based formula'8 was started, parenteral nutrition was stopped, and he began to She had been born at term after a normal pregnancy and delivery to healthy unrelated parents weighing 2-9 kg; the neonatal period was uneventful, and there was no relevant family history. From soon after birth there were intermittent episodes of diarrhoea and dehydration which did not respond to various dietary manipulations, and she was referred to us at age 3.1 months. Investigations led to a diagnosis of short segment Hirschsprung's disease and an associated mid-gut malrotation. Parenteral nutrition was instituted before surgery at 5 months, when the malrotation was corrected (Ladd's procedure), and a left transverse colostomy performed. Postoperatively, the chicken-based formula was introduced and she was discharged home at 6 months weighing 4.9 kg. Thereafter she developed recurrent episodes of watery colostomy effluent (300-600 ml/day) in association with failure to thrive, which necessitated readmission for parenteral nutrition. At age 14 months when she weighed 5.6 kg (<3rd centile), loperamide was started in a dose of 2 mg 4 times a day (1.4 mg/kg per day); on this dose colostomy output within 12 hours fell to 100-150 ml/day, and she began to thrive. At 16 months, she was discharged (7.2 kg) on the chicken-based formula and loperamide, 2 mg 4 times a day (1.1 mg/kg per day). The colostomy was closed at 2 years when she weighed 10.4 kg (1Oth centile). A normal diet was introduced at 3 years, and loperamide was stopped a month later, without recurrence ofsymptoms.
Case 5 She was born at 34 weeks' gestation to healthy unrelated parents, weighing 2-1 kg and there was no relevant family history. On day 2, intestinal obstruction was suspected and a laparotomy revealed an 'apple-peel' bowel arrangement with a dilated blind loop of ileum with some dilatation of distal jejunum, and an absent superior mesenteric artery. The dilated bowel was resected and a jejuno-ileal anastomosis performed. Postoperatively attempts at oral feeding were unsuccessful and her weight fell to 1.5 kg and she was referred to us at age 3 weeks. Parenteral nutrition was instituted and 2 weeks later oral feeding was attempted but she developed signs of intestinal obstruction. Laparotomy showed extensive adhesions and a dilated jejunum; the dilated jejunum was resected and an anastomosis between the D-J flexure and ileum performed, leaving 40 cm of small bowel. Parenteral feeding was continued, her stools remained loose, and 2 weeks later nasogastric feeding was started with Pregestimil. The stools became looser and more frequent (8-12 daily), and contained up to 2 % reducing substances. At 14 weeks she weighed 2 kg (<3rd centile) and loperamide was started in a dose of 1 mg 3 times a day (1 5 mg/kg per day) and slowly increased to 2 mg 4 times a day (3-8 mg/kg per day) over a period of one week. This resulted in the stools becoming formed and less frequent (2-4 daily) and she began to gain weight at a rate of 250-350 g a week. The feeds were changed from nasogastric to oral 3-hourly and she was discharged on Pregestimil and loperamide, 3 mg 4 times a day (2 mg/kg per day) aged 6 months weighing 5.9 kg (3rd-lOth centiles). At 14 months she weighed 9.3 kg (25th-50th centiles), loperamide was gradually stopped and a normal diet successfully introduced.
Case 6 She was born at term after an uneventful pregnancy and delivery to healthy unrelated parents, weighing 2.9 kg, and there was no relevant family history. She was exclusively breast-fed for the first month of life, and thereafter with a cows' milk formula. At 10 weeks, she was admitted because of an acute episode of vomiting and diarrhoea, and dehydration; rotavirus was isolated from the stools. Dehydration was corrected with intravenous fluids but the watery diarrhoea persisted (8-10 stools daily) for more than 2 weeks and she lost weight. The stools no longer contained any pathogens but the diarrhoea persisted despite nothing by mouth. On There is little doubt in our experience that loperamide can be a life-saving drug in some infants with severe protracted diarrhoeal states in whom dietary manipulations have failed to control the diarrhoea, and in whom diarrhoea persists despite nothing by mouth; usually parenteral nutrition is essential in these patients. Not every patient responds to the drug, and the reasons for this lack of response require clarification so that patients can be selected.
As an opiate analogue, loperamide has an effect on smooth muscle6 7 as well as on transport of fluid and electrolytes8-"1 and this should be borne in mind when using the drug in ill patients similar to those reported in this paper. For example, 2 very ill infants developed ileus while receiving loperamide and the ileus resolved when the drug was stopped. Some metabolic abnormalities may predispose to ileus, as in hypokalaemia, and we strongly recommend frequent monitoring of plasma potassium in any sick infant receiving loperamide. 
